Academic Journal
Προβολή σε EDS
Συνδεδεμένο Πλήρες Κείμενο

Changes in Stimulant Use Over Time Among Men Who Have Sex with Men in Philadelphia, Baltimore, and Washington, DC, 2008-2023.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Changes in Stimulant Use Over Time Among Men Who Have Sex with Men in Philadelphia, Baltimore, and Washington, DC, 2008-2023.
Συγγραφείς: German D; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Behavior and Society, 615 North Wolfe Street, Baltimore, MD, USA. danielle.german@jhu.edu., Nassau T; Philadelphia Department of Public Health, Philadelphia, PA, USA., Yenokyan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Li X; District of Columbia Department of Health, Washington, DC, USA., Bornstein S; Department of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, DC, USA., Drezner K; District of Columbia Department of Health, Washington, DC, USA., Hoj T; District of Columbia Department of Health, Washington, DC, USA., Gribbin M; Maryland Department of Health, Baltimore, MD, USA., Flynn C; Maryland Department of Health, Baltimore, MD, USA., Brady KA; Philadelphia Department of Public Health, Philadelphia, PA, USA., Kuo I; Department of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, DC, USA.
Πηγή: AIDS and behavior [AIDS Behav] 2026 Sep; Vol. 30 (9), pp. 2694-2707. Date of Electronic Publication: 2026 Mar 31.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE
Imprint Name(s): Publication: 2005- : New York, NY : Springer Science + Business Media
Original Publication: New York, NY : Plenum Press, 1997-
Ιατρικοί όροι (MeSH): Homosexuality, Male*/statistics & numerical data , Homosexuality, Male*/psychology , Methamphetamine*/administration & dosage , HIV Infections*/epidemiology , HIV Infections*/prevention & control , Cocaine-Related Disorders*/epidemiology , Substance-Related Disorders*/epidemiology , Central Nervous System Stimulants*/administration & dosage, Baltimore/epidemiology ; Philadelphia/epidemiology ; District of Columbia/epidemiology ; Cocaine/administration & dosage ; Crack Cocaine/administration & dosage ; Humans ; Male ; Adult ; Cross-Sectional Studies ; Prevalence ; Young Adult ; Risk-Taking ; Middle Aged
Περίληψη: Stimulant use among men who have sex with men (MSM) can contribute to HIV risk and care challenges. Monitoring and responding to local trends are critical for Ending the HIV Epidemic (EHE) initiatives. We assessed stimulant use patterns in Baltimore, Philadelphia, and Washington, DC from 2008 to 2023 using National HIV Behavioral Surveillance data. We collected cross-sectional data in each city using venue-based sampling in 2008, 2011, 2014, 2017, and 2023. We estimated average predicted probabilities of methamphetamine, powder cocaine, and crack cocaine use, and evaluated differences in prevalence of stimulant use overall and by race/ethnicity. In DC, stimulant use was stable or declined. Methamphetamine use remained stable overall (8%), with observed decreases among Hispanic MSM (13% to 4%). In Baltimore, methamphetamine use increased (2% to 5%) overall, while powder cocaine slightly declined overall (15% to 13%), with decreases among Black MSM but increases among White and Hispanic MSM. Crack cocaine decreased slightly (12% to 11%). In Philadelphia, methamphetamine use rose substantially (3% to 10%), with the largest increase among White MSM (3% to 19%). Powder cocaine use was highest in Philadelphia, reaching 41% among White MSM in 2023. Trends in stimulant use among MSM differed across these three EHE-funded cities. Philadelphia showed pronounced increases, particularly among White MSM, while DC and Baltimore exhibited more modest or stable patterns. Comparable local data sources are essential for identifying city- and subpopulation-specific trends to inform focused, equitable prevention strategies within EHE.
(© 2026. The Author(s).)
Competing Interests: Declarations. Conflict of interest: DG serves on the Consulting Editorial Board of AIDS and Behavior. The authors have no other competing interests to disclose. Research involving Human and animal participants: For Washington, DC, the DC Department of Health IRB and the George Washington University IRB reviewed and approved NHBS protocols. For Philadelphia, the City of Philadelphia Department of Public Health IRB reviewed and approved NHBS protocols. For Baltimore, the NHBS protocol and all local materials were approved by Institutional Review Boards at the Johns Hopkins Bloomberg School of Public Health and the Maryland Department of Health. Informed consent form: Eligible participants completed informed consent procedures prior to survey and optional HIV pre- and post-test counseling procedures. A waiver of written consent was granted by the CDC and IRBs due to the sensitive nature of the data collected. Therefore, only verbal consent was provided by participants which was documented by study staff.
References: Addiction. 2022 Mar;117(3):656-665. (PMID: 34402120)
AIDS Behav. 2026 Sep;30(9):2646-2657. (PMID: 41712052)
PLoS One. 2020 Jun 18;15(6):e0234809. (PMID: 32555667)
Addiction. 2020 Jan;115(1):175-183. (PMID: 31321853)
Public Health Rep. 2007;122 Suppl 1:39-47. (PMID: 17354526)
AIDS. 2025 May 01;39(6):708-718. (PMID: 39832182)
AIDS Behav. 2022 Sep;26(9):3016-3028. (PMID: 35303188)
Lancet. 2021 Mar 20;397(10279):1116-1126. (PMID: 33617771)
J Gay Lesbian Soc Serv. 2018;30(1):82-101. (PMID: 30381785)
AIDS Behav. 2021 Apr;25(4):1210-1218. (PMID: 33185774)
AIDS Behav. 2021 Nov;25(11):3574-3604. (PMID: 33866444)
J Int AIDS Soc. 2018 Mar;21(3):e25103. (PMID: 29577616)
Int J Drug Policy. 2019 Jan;63:74-89. (PMID: 30513473)
Public Health Rep. 2007;122 Suppl 1:32-8. (PMID: 17354525)
MMWR Morb Mortal Wkly Rep. 2025 Aug 28;74(32):491-499. (PMID: 40875496)
Curr Opin Neurobiol. 2024 Aug;87:102898. (PMID: 39096558)
MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1201-1206. (PMID: 36136909)
Subst Use Misuse. 2022;57(4):595-602. (PMID: 35068332)
Addiction. 2019 Nov;114(11):2065-2077. (PMID: 31321819)
Drug Alcohol Depend. 2022 Mar 1;232:109320. (PMID: 35093681)
Am J Public Health. 2003 Nov;93(11):1915-21. (PMID: 14600066)
Subst Use Misuse. 2023;58(5):728-734. (PMID: 36872623)
JAMA. 2019 Mar 5;321(9):844-845. (PMID: 30730529)
Int J Drug Policy. 2023 Feb;112:103949. (PMID: 36587507)
J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S296-S308. (PMID: 28604431)
Am J Public Health. 2020 Jan;110(1):22-24. (PMID: 31725312)
Subst Use Misuse. 2021;56(1):111-122. (PMID: 33153358)
Lancet. 2019 Nov 2;394(10209):1652-1667. (PMID: 31668409)
JMIR Public Health Surveill. 2022 Nov 15;8(11):e39053. (PMID: 36378503)
N Engl J Med. 2021 Jul 22;385(4):352-356. (PMID: 34289278)
AIDS Behav. 2012 Jan;16(1):151-8. (PMID: 21191644)
Sex Transm Dis. 2021 Aug 1;48(8S):S32-S39. (PMID: 33967238)
Sex Transm Infect. 2017 Aug;93(5):342-346. (PMID: 28400466)
Drug Alcohol Depend. 2010 Jul 1;110(1-2):30-7. (PMID: 20334986)
J Infect Dis. 2016 Mar 1;213(5):776-83. (PMID: 26486637)
Drug Alcohol Depend. 2021 Jan 1;218:108416. (PMID: 33278761)
Drug Alcohol Depend. 2014 Jun 1;139:174-7. (PMID: 24726318)
J Addict Med. 2024 May-Jun 01;18(1S Suppl 1):1-56. (PMID: 38669101)
J Psychiatr Res. 2021 Mar;135:107-118. (PMID: 33472121)
J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S288-S295. (PMID: 28604430)
Drug Alcohol Depend. 2021 Mar 1;220:108516. (PMID: 33485009)
Am J Prev Med. 2020 Nov;59(5):686-696. (PMID: 32981768)
Curr Infect Dis Rep. 2018 Jul 31;20(9):36. (PMID: 30066113)
AIDS Care. 2004 Nov;16(8):1036-47. (PMID: 15511735)
AIDS. 2013 Nov 13;27(17):2665-78. (PMID: 23842129)
Grant Information: P30 AI094189 United States AI NIAID NIH HHS; NU62PS924759 United States CC CDC HHS; 6NU62PS924769 United States CC CDC HHS; NU62PS924777 United States CC CDC HHS; NU62PS924759 United States JG JG CDC HHS; 6NU62PS924769 United States JG JG CDC HHS; NU62PS924777 United States JG JG CDC HHS
Contributed Indexing: Keywords: Cocaine; Crack; MSM; Methamphetamine; Mid-Atlantic; Stimulants
Local Abstract: [Publisher, Spanish; Castilian] El consumo de estimulantes entre hombres que tienen sexo con hombres (HSH) contribuye al riesgo de VIH y a desafíos en la atención médica. El monitoreo y la respuesta a las tendencias locales son fundamentales para las iniciativas de Acabar con la Epidemia del VIH (EHE, por sus siglas en inglés). Evaluamos los patrones de consumo de estimulantes en Baltimore, Philadelphia y Washington, DC de 2008 a 2023 utilizando datos de la Vigilancia Nacional del Comportamiento frente al VIH. Recopilamos datos transversales en cada ciudad utilizando muestreo basado en lugares en 2008, 2011, 2014, 2017 y 2023. Estimamos las probabilidades promedio predichas del consumo de metanfetamina, cocaína en polvo y crack, y evaluamos las diferencias en la prevalencia del consumo de estimulantes en general y por raza/etnicidad. En DC, el consumo de estimulantes se mantuvo estable o disminuyó. El consumo de metanfetamina se mantuvo estable en general (8%), con disminuciones observadas entre HSH hispanos (13% a 4%). En Baltimore, el consumo de metanfetamina aumentó (2% a 5%) en general, mientras que el consumo de cocaína en polvo disminuyó ligeramente en general (15% a 13%), con disminuciones entre HSH negros pero aumentos entre HSH blancos e hispanos. El crack disminuyó ligeramente (12% a 11%). En Philadelphia, el consumo de metanfetamina aumentó sustancialmente (3% a 10%), con el mayor incremento entre HSH blancos (3% a 19%). El consumo de cocaína en polvo fue más alto en Philadelpha, alcanzando el 41% entre HSH blancos en 2023. Las tendencias en el consumo de estimulantes entre HSH difirieron en estas tres ciudades financiadas por EHE. Philadelphia mostró aumentos pronunciados, particularmente entre HSH blancos, mientras que DC y Baltimore exhibieron patrones más modestos o estables. Fuentes de datos locales comparables son esenciales para identificar tendencias específicas por ciudad y subpoblación que informen estrategias de prevención enfocadas y equitativas dentro de EHE.
Substance Nomenclature: 44RAL3456C (Methamphetamine)
I5Y540LHVR (Cocaine)
0 (Crack Cocaine)
0 (Central Nervous System Stimulants)
Entry Date(s): Date Created: 20260331 Date Completed: 20260917 Latest Revision: 20260919
Update Code: 20260919
PubMed Central ID: PMC13202489
DOI: 10.1007/s10461-026-05098-2
PMID: 41915291
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1573-3254
DOI:10.1007/s10461-026-05098-2